However, compared to the ISO group, the promotion of myocardial cell apoptosis decreased, which suggests that SDSL may be a targeted biomarker for heart failure, as it can regulate PRAP1 and inhibit ISO-induced myocardial cell apoptosis. This evidence concerns the gene SDSL and heart failure.